Literature DB >> 19932530

Synthesis, antitumor activity and molecular docking study of novel sulfonamide-Schiff's bases, thiazolidinones, benzothiazinones and their C-nucleoside derivatives.

Mohsen M Kamel1, Hamed I Ali, Manal M Anwar, Neama A Mohamed, Abdelmohsen M Soliman.   

Abstract

A series of sulfapyridine-polyhydroxyalkylidene (or arylidene)-imino derivatives (Schiff's bases) 2a-c and 4a-e were prepared by condensation of 4-amino-N-pyridin-2-ylbenzenesulfonamide (1) with different monosaccharides or with aromatic aldehydes. Treatment of 2a-c with thioglycolic acid led to the formation of the C-nucleosides (3a-c), while treatment of 4a-e with thioglycolic and/or thiosalicylic acids afforded the corresponding 2-arylthiazolidin-4-one or 2-arylbenzothiazin-4-one derivatives 5a-e and/or 6a-e, respectively. Some representative examples of the newly prepared compounds showed considerable cytotoxic effect against breast carcinoma cell line MCF7 and cervix carcinoma cell line HELA in comparison with 5-flurouracil and doxorubicin. AutoDock molecular docking into PTK has been done for lead optimization of the compounds in study as potential PTK inhibitors. Copyright 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19932530     DOI: 10.1016/j.ejmech.2009.10.044

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  15 in total

1.  Convenient diastereoselective synthesis of annulated 3-substituted-(5S*,6S*,Z)-2-(2-(2,4-dinitrophenyl)hydrazono)-5,6-diphenyl-1,3-thiazinan-4-ones.

Authors:  Alaa A Hassan; Nasr K Mohamed; Ashraf A Aly; Hendawy N Tawfeek; Henning Hopf; Stefan Bräse; Martin Nieger
Journal:  Mol Divers       Date:  2019-01-03       Impact factor: 2.943

2.  Binding site and affinity prediction of general anesthetics to protein targets using docking.

Authors:  Renyu Liu; Jose Manuel Perez-Aguilar; David Liang; Jeffery G Saven
Journal:  Anesth Analg       Date:  2012-03-05       Impact factor: 5.108

3.  Antioxidant and cytotoxic activities of selected salicylidene imines: experimental and computational study.

Authors:  Jovica Branković; Marios G Krokidis; Irini Dousi; Kyriakos Papadopoulos; Zorica D Petrović; Vladimir P Petrović
Journal:  Mol Divers       Date:  2022-02-11       Impact factor: 2.943

4.  New organosulfur metallic compounds as potent drugs: synthesis, molecular modeling, spectral, antimicrobial, drug likeness and DFT analysis.

Authors:  Abrar Ul Hassan; Sajjad Hussain Sumrra; Muhammad Nadeem Zafar; Muhammad Faizan Nazar; Ehsan Ullah Mughal; Muhammad Naveed Zafar; Mazhar Iqbal
Journal:  Mol Divers       Date:  2021-01-07       Impact factor: 2.943

5.  4-[(E)-(2,4,5-Trimeth-oxy-benzyl-idene)amino]-1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one.

Authors:  Hoong-Kun Fun; Madhukar Hemamalini; Abdullah M Asiri; Salman A Khan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-06-16

6.  2-(3-Nitro-phen-yl)-3-phenyl-2,3-di-hydro-4H-1,3-benzo-thia-zin-4-one.

Authors:  Hemant P Yennawar; Lee J Silverberg; Michael J Minehan; John Tierney
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-10-23

7.  Crystal structure of 2,3-diphenyl-2,3-di-hydro-4H-1,3-benzo-thia-zin-4-one 1-oxide.

Authors:  Hemant P Yennawar; Ryan Fox; Quentin J Moyer; Ziwei Yang; Lee J Silverberg
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-07-17

8.  2,3-Diphenyl-2,3-di-hydro-4H-1,3-benzo-thia-zin-4-one.

Authors:  Hemant P Yennawar; Ryan V Bendinsky; David J Coyle; Aaron S Cali; Lee J Silverberg
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-03-22

9.  Crystal structures of two 2,3-diaryl-2,3-di-hydro-4H-1,3-benzo-thia-zin-4-ones.

Authors:  Hemant P Yennawar; Michaela J Buchwalter; Baylee K Colburn; Lee J Silverberg
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-02-20

10.  Design, synthesis, characterization and computational docking studies of novel sulfonamide derivatives.

Authors:  Hira Saleem; Arooma Maryam; Saleem Ahmed Bokhari; Ayesha Ashiq; Sadaf Abdul Rauf; Rana Rehan Khalid; Fahim Ashraf Qureshi; Abdul Rauf Siddiqi
Journal:  EXCLI J       Date:  2018-02-01       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.